EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieKlinische StudieOpen Access · CC BY 4.0

Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction

Mike J P de Jong iD, Foke van Delft, Erwin-Jan M van Geenen, Auke Bogte, Robert C Verdonk, Niels G Venneman, Jan Maarten Vrolijk, Jan-Willem A Straathof, Rogier P Voermans iD, Rina A Bijlsma, Sjoerd D Kuiken, Rutger Quispel iD und 8 weitere

Endoscopy · 01.09.2025 · 57 (09) · 1004-1015

DOI: 10.1055/a-2580-1316 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.09.2025. Verfasst von Mike J P de Jong und 19 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, Netherlands. Hauptthemen laut MEDLINE: Drainage, Choledochostomy, Cholestasis, Endosonography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Percutaneous transhepatic biliary drainage (PTBD) and endoscopic ultrasound-guided biliary drainage (EUS-BD), including choledochoduodenostomy (EUS-CDS), are alternative methods for biliary drainage in patients with distal malignant biliary obstruction (MBO) after failed endoscopic retrograde cholangiopancreatography (ERCP). Data on long-term outcomes, adverse events (AEs), and quality of life (QoL) after EUS-CDS and PTBD are limited. Therefore, we created a registry to evaluate the outcomes of both drainage procedures. Patients with distal MBO who underwent EUS-CDS or PTBD after unsuccessful ERCP were included in this multicenter investigator-initiated prospective registry over an 18-month inclusion period. Primary end points were procedure-related AEs and mortality within 90 days post-procedure. Secondary end points included technical and clinical success, reinterventions, hospital stay, and QoL. 55 patients were included, with 12 patients undergoing PTBD (technical success 100%) and 43 patients EUS-CDS (technical success 97.7%). Prior to ERCP, 7/12 patients in the PTBD group and 12/43 patients in the EUS-CDS group opted for best supportive care. The 90-day mortality rate was 66.7% in the PTBD group and 20.9% in the EUS-CDS group (P = 0.005). Furthermore, 11/12 patients (91.7%) in the PTBD group and 19/43 (44.2%) in the EUS-CDS group developed one or more AEs (P = 0.004). The median post-procedural hospital stay was 4 days (interquartile range [IQR] 2–6) in the PTBD group vs. 1 day (IQR 1–2) in the EUS-CDS group (P = 0.001). When both modalities were available and technically feasible, gastroenterologists preferred EUS-CDS over PTBD. EUS-CDS seems to be associated with lower mortality and AE rates, shorter hospital admission, and fewer reinterventions, but a randomized controlled trial should confirm these observations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DrainageCholedochostomyCholestasisEndosonographyPostoperative ComplicationsHumansMaleFemaleAgedCholangiopancreatography, Endoscopic RetrogradeMiddle AgedUltrasonography, InterventionalProspective StudiesQuality of LifeAged, 80 and overRegistriesBile Duct NeoplasmsLength of StayTreatment Failure

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Research and Development, St Antonius Hospital, Nieuwegein, Netherlands.
  • Gastroenterology and Hepatology, UMC Utrecht, Utrecht, Netherlands.
  • Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, Netherlands.
  • Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, Netherlands.
  • Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, Netherlands.

ORCID-Profile: Mike J P de Jong, Rogier P Voermans, Rutger Quispel, Kirill Basiliya, Roy L J van Wanrooij

Zitieren

APA

de Jong, M. J. P., van Delft, F., van Geenen, E. M., Bogte, A., Verdonk, R. C., Venneman, N. G., Vrolijk, J. M., Straathof, J. A., Voermans, R. P., Bijlsma, R. A., Kuiken, S. D., Quispel, R., Hadithi, M., Basiliya, K., Vleggaar, F. P., Bisseling, T. M., de Wijkerslooth, T. R., Bruno, M. J., van Wanrooij, R. L. J., & Siersema, P. D. (2025). Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction. Endoscopy, 57(09), 1004-1015. https://doi.org/10.1055/a-2580-1316

Vancouver

de Jong MJP, van Delft F, van Geenen EM, Bogte A, Verdonk RC, Venneman NG, et al. Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction. Endoscopy. 2025;57(09):1004-1015. doi:10.1055/a-2580-1316

BibTeX
@article{deJong2025,
  author = {de Jong, Mike J P and van Delft, Foke and van Geenen, Erwin-Jan M and Bogte, Auke and Verdonk, Robert C and Venneman, Niels G and Vrolijk, Jan Maarten and Straathof, Jan-Willem A and Voermans, Rogier P and Bijlsma, Rina A and Kuiken, Sjoerd D and Quispel, Rutger and Hadithi, Muhammed and Basiliya, Kirill and Vleggaar, Frank P and Bisseling, Tanya M and de Wijkerslooth, Thomas R and Bruno, Marco J and van Wanrooij, Roy L J and Siersema, Peter D},
  title = {Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {09},
  pages = {1004--1015},
  doi = {10.1055/a-2580-1316}
}
Kostenlos starten →